Live Analyst Rating Changes 26406 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Thomas Flaten
LS

Thomas Flaten

Lake Street
Wall Street Analyst
★★★★☆
#501
on 13Foresight · ranked by our own returns
63%
Success Rate
+7.9%
Average Return
24 of 38 calls profitable · +29.6% vs benchmark
S&P 500 (SPY)
🔒 5-year track record is Pro. Showing 1-year — upgrade.
📈 Across the calls we could measure, roughly 63% of Thomas Flaten's ratings turned a profit when each position was held for 1 year — averaging +7.9% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

117 Buy 7 Hold 0 Sell
Thomas's Stock Coverage 22 ratings · 2026-08-21
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
HROW
Harrow Health
 Aug 20, 2026 BUY Strong Buy
+28.9% avg upside
12 analysts
$60.00
42.61% Upside
 · ·
AEON
AEON Biopharma
 Aug 19, 2026 BUY Strong Buy
+469.7% avg upside
2 analysts
$1.00
417.95% Upside
 · ·
IMDX
Insight Molecular Diagnostics
 Aug 18, 2026 BUY Buy
+24.5% avg upside
10 analysts
$12.00
179.07% Upside
 · ·
EVAX
Evaxion Biotech
 Aug 17, 2026 BUY Strong Buy
+289.6% avg upside
6 analysts
$9.00
174.43% Upside
 +4.8% ·
AQST
Aquestive Therapeutics
 Aug 10, 2026 BUY Strong Buy
+99.9% avg upside
10 analysts
$6.00
33.43% Upside
 +1.1% ·
RPID
Rapid Micro Biosystems
 Aug 10, 2026 BUY Strong Buy
+424.0% avg upside
6 analysts
$7.00
319.13% Upside
 -0.6% ·
BLFS
BioLife Solutions
 Aug 07, 2026 HOLD Buy
-20.3% avg upside
17 analysts
$31.00
16.19% Downside
 +5.2% ·
PSNL
Personalis
 Aug 05, 2026 HOLD Strong Buy
-10.9% avg upside
11 analysts
$16.25
3.76% Downside
 +2.1% ·
CSTL
Castle Biosciences
 Jul 31, 2026 BUY Strong Buy
+26.7% avg upside
9 analysts
$57.00
73.18% Upside
 +15.4% ·
CNTB
Connect Biopharma Holdings
 Jul 15, 2026 BUY Strong Buy
+186.6% avg upside
12 analysts
$9.00
294.74% Upside
 +4.9% ·
DMAC
Diamedica Therapeutics
 Jun 23, 2026 BUY Strong Buy
+125.9% avg upside
12 analysts
$14.00
114.69% Upside
 +8.4% ·
AYTU
Aytu BioScience
 May 14, 2026 BUY Strong Buy
+712.0% avg upside
7 analysts
$7.00
206.98% Upside
 +4.9% ·
DERM
Journey Medical Corp
 May 14, 2026 BUY Strong Buy
+60.2% avg upside
11 analysts
$13.00
73.50% Upside
 +17.9% ·
MDXH
MDxHealth
 May 14, 2026 BUY Strong Buy
+713.4% avg upside
9 analysts
$5.00
594.51% Upside
 -23.8% ·
ARLO
Arlo Technologies
 May 08, 2026 BUY Strong Buy
+32.6% avg upside
12 analysts
$24.00
84.04% Upside
 -11.8% ·
BDSX
Biodesix
 May 05, 2026 BUY Strong Buy
+41.9% avg upside
9 analysts
$40.00
66.43% Upside
 +60.6% ·
ACHV
Achieve Life Sciences
 Apr 15, 2026 BUY Strong Buy
+91.6% avg upside
15 analysts
$11.00
37.19% Upside
 +107.9% ·
PTHS
Pelthos Therapeutics
 Mar 25, 2026 BUY Strong Buy
+97.5% avg upside
8 analysts
$50.00
87.60% Upside
 +21.0% ·
BTTX
Better Therapeutics
 Nov 29, 2023 BUY Strong Buy
+1499900.1% avg upside
3 analysts
$1.50
1499900.08% Upside
 · ·
ENSC
Ensysce Biosciences
 Apr 12, 2023 BUY Buy
+3870.4% avg upside
3 analysts
$15.00
3870.40% Upside
 · ·
TCRT
Alaunos Therapeutics
 Sep 16, 2022 BUY Buy
+733.7% avg upside
13 analysts
$3.50
94.39% Upside
 · ·
VCYT
Veracyte
 Mar 01, 2022 BUY Strong Buy
+21.1% avg upside
19 analysts
$50.00
19.62% Upside
 -15.5% ·
🔒 17 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Thomas Flaten — Frequently Asked Questions
How accurate are Thomas Flaten's stock ratings?
Based on the calls 13Foresight could measure, about 62% of Thomas's ratings were profitable over a one-year hold, with an average return of +8.0% per rating, or +30.4% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Thomas ranked on 13Foresight?
Thomas Flaten is currently ranked #501 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Thomas cover?
Thomas most recently has ratings on HROW, AEON, IMDX, EVAX, AQST, RPID, BLFS, PSNL, CSTL, CNTB, DMAC, AYTU and 10 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.